PROGNOSTIC VALUE OF ADDITIONAL CHROMOSOMAL ABERRATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON TYROSINEKINASE INHIBITORS THERAPY

Prognostic significance of additional chromosomal abnormalities (ACAs) for tyrosinekinase inhibitors therapy (TKI) response in chronic myeloid leukemia (CML) patients is discussed. In many ways, this uncertainty is dueto the low frequency as well as the high variability of ACAs in patients with chro...

Full description

Bibliographic Details
Main Authors: Dmytrenko I. V., Minchenko Zh. M., Fedorenko V. G., Dyagil I. S.
Format: Article
Language:English
Published: Ukrainian Medical Stomatological Academy 2019-04-01
Series:Вісник проблем біології і медицини
Subjects:
Online Access: https://vpbm.com.ua/upload/2019-2-1/51-min.pdf